Thrixopelma pruriens, known as the Peruvian green velvet tarantula,[2] is a species of tarantula found in Chile in South America (not Peru).[1][3]
Though docile, this species is rarely kept as a pet in part due to its tendency to fling urticating hairs with minimal provocation.[4]
In 2014, researchers at Yale University identified a toxin called Protoxin-I from the tarantula's venom that shows promise as a new painkiller drug.[5] The toxin reduces activity in an ion channel associated with inflammation and neuropathic pain, making it potentially suitable as a treatment for both normal pain and pathological pain syndromes.[6][2]
Thrixopelma pruriens, known as the Peruvian green velvet tarantula, is a species of tarantula found in Chile in South America (not Peru).
Though docile, this species is rarely kept as a pet in part due to its tendency to fling urticating hairs with minimal provocation.
In 2014, researchers at Yale University identified a toxin called Protoxin-I from the tarantula's venom that shows promise as a new painkiller drug. The toxin reduces activity in an ion channel associated with inflammation and neuropathic pain, making it potentially suitable as a treatment for both normal pain and pathological pain syndromes.
